EyePoint Pharmaceuticals to Pay Nearly $4.7 Million to Settle FCA Allegations July 24, 2026 Written by AHLA Legal Staff Share this: facebook twitter linkedin ARTICLE TAGS Fraud and Compliance You must be logged in to access this content. Log in